Your browser doesn't support javascript.
loading
Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
Liu, Qian; Li, Anping; Yu, Shengnan; Qin, Shuang; Han, Na; Pestell, Richard G; Han, Xinwei; Wu, Kongming.
Affiliation
  • Liu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
  • Li A; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
  • Yu S; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
  • Qin S; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
  • Han N; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
  • Pestell RG; Pennsylvania Cancer and Regenerative Medicine Research Center, Wynnewood, PA, 19096, USA.
  • Han X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China. hanxinwei2006@163.com.
  • Wu K; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China. kmwu@tjh.tjmu.edu.cn.
J Hematol Oncol ; 15(1): 175, 2022 Dec 13.
Article in En | MEDLINE | ID: mdl-36514108

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Hematol Oncol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Hematol Oncol Year: 2022 Document type: Article